Average Co-Inventor Count = 7.76
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (11 from 329 patents)
2. Knopp Biosciences, LLC (9 from 27 patents)
3. Biohaven Therapeutics Ltd. (4 from 29 patents)
4. Amgen Inc. (1 from 1,974 patents)
24 patents:
1. 12351559 - Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators
2. 12286408 - KV7 channel activators compositions and methods of use
3. 11834418 - Benzoimidazol-1,2-yl amides as Kv7 channel activators
4. 11724990 - Kv7 channel activators compositions and methods of use
5. 11261162 - KV7 channel activators compositions and methods of use
6. 10906877 - Benzoimidazol-1,2-yl amides as Kv7 channel activators
7. 10851067 - Kv7 channel activators compositions and methods of use
8. 10669269 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
9. 10526328 - Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activators
10. 10385025 - Benzoimidazol-1,2-yl amides as Kv7 channel activators
11. 10106536 - Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators
12. 9914708 - Benzoimidazol-1,2-yl amides as Kv7 channel activators
13. 9809590 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
14. 9650376 - [object Object]
15. 9481653 - Benzoimidazol-1,2-yl amides as Kv7 channel activators